New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2013
10:00 EDTBBT, AMTG, QLIK, PKI, PRI, MVO, MAKO, GPN, HILL, D, CYS, BCRXOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: BB&T (BBT) upgraded to Buy from Neutral at Compass Point... CYS Investments (CYS) upgraded to Buy from Neutral at Compass Point... Dominion (D) upgraded to Overweight from Neutral at Atlantic Equities... Dot Hill Systems (HILL) upgraded to Buy from Hold at Needham... Global Payments (GPN) upgraded to Buy from Neutral at Nomura... MAKO Surgical (MAKO) upgraded to Buy from Neutral at Mizuho... MV Oil Trust (MVO) upgraded to Market Perform from Underperform at Raymond James... Primerica (PRI) upgraded to Outperform from Market Perform at Raymond James... Qlik Technologies (QLIK) upgraded to Overweight from Equal Weight at Evercore... PerkinElmer (PKI) upgraded to Strong Buy from Buy at ISI Group... Apollo Residential Mortgage (AMTG) upgraded to Overweight from Neutral at JPMorgan... BioCryst (BCRX) upgraded to Buy from Hold at MLV Equity.
News For BBT;CYS;D;HILL;GPN;MAKO;MVO;PRI;PKI;QLIK;AMTG;BCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 12, 2014
19:12 EDTBCRXCDC confirms Texas healthcare worker positive for Ebola
Subscribe for More Information
14:18 EDTBCRXNY's JFK Airport begins Ebola screenings, WSJ says
Subscribe for More Information
12:48 EDTBCRXTexas health-care worker tests positive for Ebola, WSJ says
Subscribe for More Information
October 10, 2014
10:54 EDTBCRXMapp looking to up production of experimental Ebola treatment, WSJ says
Mapp Biopharmaceutical is aiming to broaden the manufacturing of its experimental Ebola treatment, ZMapp, according to The Wall Street Journal, citing comments from the company. Mapp said that the treatment was given to a few infected individuals prior to supplies running out two months ago. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
October 9, 2014
14:55 EDTBCRXHospital says deputy showing no signs of Ebola, AP reports
Subscribe for More Information
14:24 EDTBCRXCDC head compares Ebola to AIDS, Washington Post says
Subscribe for More Information
14:13 EDTBCRXFirst Ebola vaccine trial in West Africa started, NBC News reports
Subscribe for More Information
12:06 EDTBCRXLakeland Industries continues surge amid Ebola fears
Subscribe for More Information
08:02 EDTQLIKQlik Technologies announces partnership with Fujitsu
Subscribe for More Information
October 8, 2014
11:22 EDTBCRXChimerix falls after Ebola patient taking experimental drug dies
Shares of Chimerix (CMRX) are moving lower after the Texas Health Presbyterian Hospital Dallas announced that Thomas Eric Duncan succumbed to Ebola. Duncan was being treated with Chimerix's experimental drug Brincidofovir. Shares of Chimerix dropped 9% following the news to $30.19. Other makers of experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT) and BioCryst (BCRX).
07:11 EDTBCRXEuropean Academy of Dermatology and Venereology to hold a conference
23rd EADV Congress is being held in Amsterdam, The Netherlands on October 8-12.
06:28 EDTBBTM&T Bank, SunTrust may miss Q3 expectations, says Citigroup
Subscribe for More Information
October 7, 2014
10:02 EDTBBTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:59 EDTBBTBB&T initiated with a Market Perform at Bernstein
Target $41.
07:45 EDTBCRXBioCryst up 2.2% after OPuS-1 Phase 2 trial met primary efficacy endpoint
Subscribe for More Information
07:14 EDTBCRXBioCryst announces OPuS-1 Phase 2 trial met primary efficacy endpoint
Subscribe for More Information
October 6, 2014
14:09 EDTQLIKSplunk, Tableau seen by Morgan as well-positioned in Big Data space
Subscribe for More Information
10:04 EDTQLIKOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abercrombie & Fitch (ANF) downgraded to Neutral from Overweight at Piper Jaffray... Air France-KLM (AFLYY) downgraded to Neutral from Buy at Citigroup... BAE Systems (BAESY) downgraded to Hold from Buy at Societe Generale... Buffalo Wild Wings (BWLD) downgraded to Neutral from Outperform at Wedbush... Church & Dwight (CHD) downgraded to Underweight from Equal Weight at Barclays... Colgate-Palmolive (CL) downgraded to Equal Weight from Overweight at Barclays... Deckers Outdoor (DECK) downgraded to Neutral from Overweight at Piper Jaffray... Delhaize (DEG) downgraded to Hold from Buy at Deutsche Bank... Fortinet (FTNT) downgraded to Equal Weight from Overweight at Morgan Stanley... McDonald's (MCD) downgraded to Equal Weight from Overweight at Morgan Stanley... Midcoast Energy (MEP) downgraded to Neutral from Buy at UBS... Mobileye (MBLY) downgraded to Market Perform from Outperform at Raymond James... Myers Industries (MYE) downgraded to Neutral from Buy at CL King... Nationstar (NSM) downgraded to Underperform from Market Perform at Keefe Bruyette... PTC Therapeutics (PTCT) downgraded to Market Perform at Cowen... PetSmart (PETM) downgraded to Equal Weight from Overweight at Barclays... Qlik Technologies (QLIK) downgraded to Equal Weight from Overweight at Morgan Stanley... Subsea 7 (SUBCY) downgraded to Neutral from Outperform at Exane BNP Paribas... Tekmira (TKMR) downgraded to Market Perform from Outperform at ... XL Group (XL) downgraded to Market Perform from Outperform at FBR Capital... Xoom (XOOM) downgraded to Underweight from Equal-Weight at Evercore.
06:54 EDTDDominion Midstream Partners files 17.5M unit IPO between $19.00-$21.00
Subscribe for More Information
05:52 EDTQLIKQlik Technologies downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use